BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2987421)

  • 1. Production of and response to interleukin-2 by cultured T cells: effects of lithium chloride and other putative modulators.
    Kishter S; Hoffman FA; Pizzo PA
    J Biol Response Mod; 1985 Apr; 4(2):185-94. PubMed ID: 2987421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of immunomodulators on the production of interleukin 2].
    Skotnicki AB
    Przegl Lek; 1985; 42(7):573-9. PubMed ID: 3001837
    [No Abstract]   [Full Text] [Related]  

  • 3. Target cells for immunomodulatory action of muramyl dipeptide.
    Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
    Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muramyl dipeptide-Lys stimulates the function of human dendritic cells.
    Todate A; Suda T; Kuwata H; Chida K; Nakamura H
    J Leukoc Biol; 2001 Nov; 70(5):723-9. PubMed ID: 11698491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of colony-stimulating factor from macrophages by muroctasin.
    Yamaguchi F; Akahane K; Takashi T; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human IL 2 production by MDP and derivatives.
    Leclerc C; Morin A; Deriaud E; Chedid L
    J Immunol; 1984 Oct; 133(4):1996-2000. PubMed ID: 6332144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modulation effect of lithium on IL-2 and IFNr production by human peripheral blood mononuclear cells].
    Wu YY
    Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):337-9. PubMed ID: 1337888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM; Kumar A; Kryworuchko M; Diaz-Mitoma F
    J Immunol; 1996 Jul; 157(1):12-20. PubMed ID: 8683105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of interleukin-2 (IL-2) production by 6 different cytokines: heterogeneity among IL-2 producing T cell clones.
    Holán V; Minowada J
    Folia Biol (Praha); 1993; 39(1):1-13. PubMed ID: 8348981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements.
    Nio DA; Moylan RN; Roche JK
    J Immunol; 1993 Jun; 150(12):5281-8. PubMed ID: 8515059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells.
    Jeannin P; Delneste Y; Seveso M; Life P; Bonnefoy JY
    J Immunol; 1996 May; 156(9):3159-65. PubMed ID: 8617936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction.
    Yoshioka K; Kakumu S; Murakami H; Fukui K
    Clin Exp Immunol; 1984 Jun; 56(3):669-76. PubMed ID: 6235072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopharmacology of synthetic immunomodulators.
    Wybran J
    Prog Clin Biol Res; 1983; 132E():95-103. PubMed ID: 6196792
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunosuppressive effects of measles virus on T cell function--failure to affect IL-2 release or cytotoxic T cell activity in vitro.
    Borysiewicz LK; Casali P; Rogers B; Morris S; Sissons JG
    Clin Exp Immunol; 1985 Jan; 59(1):29-36. PubMed ID: 3156014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.